<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName journalpublishing.dtd?>
<?SourceDTD.Version 2.3?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 2?>
<front>
  <?epub May-26-2014?>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="hwp">nar</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">4086086</article-id>
    <article-id pub-id-type="pmid">24861617</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gku410</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome
                    editing</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Montague</surname>
          <given-names>Tessa G.</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
        <xref ref-type="author-notes" rid="fn1">†</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cruz</surname>
          <given-names>José M.</given-names>
        </name>
        <xref ref-type="aff" rid="aff2">
          <sup>2</sup>
        </xref>
        <xref ref-type="aff" rid="aff3">
          <sup>3</sup>
        </xref>
        <xref ref-type="author-notes" rid="fn1">†</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gagnon</surname>
          <given-names>James A.</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Church</surname>
          <given-names>George M.</given-names>
        </name>
        <xref ref-type="aff" rid="aff3">
          <sup>3</sup>
        </xref>
        <xref ref-type="aff" rid="aff4">
          <sup>4</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Valen</surname>
          <given-names>Eivind</given-names>
        </name>
        <xref ref-type="aff" rid="aff1">
          <sup>1</sup>
        </xref>
        <xref ref-type="corresp" rid="cor1">*</xref>
      </contrib>
      <aff id="aff1"><label>1</label>Department of Molecular and Cellular Biology, Harvard
                    University, Cambridge, MA 02138, USA</aff>
      <aff id="aff2"><label>2</label>Harvard School of Engineering and Applied Sciences,
                    Cambridge, MA 02138, USA</aff>
      <aff id="aff3"><label>3</label>Wyss Institute for Biologically Inspired Engineering,
                    Harvard University, Cambridge, MA 02138, USA</aff>
      <aff id="aff4"><label>4</label>Department of Genetics, Harvard Medical School,
                    Boston, MA 02115, USA</aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>To whom correspondence should be addressed. Tel:
                    +1 617 496 4910; Fax: +1 617 495 9300; Email:
                        <email>eivind.valen@gmail.com</email></corresp>
      <fn id="fn1">
        <label>†</label>
        <p>The authors wish it to be known that, in their opinion, the first two authors
                        should be regarded as Joint First Authors.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="ppub">
      <day>01</day>
      <month>7</month>
      <year>2014</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>26</day>
      <month>5</month>
      <year>2014</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>26</day>
      <month>5</month>
      <year>2014</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="epub"/>. -->
    <volume>42</volume>
    <issue>Web Server issue</issue>
    <fpage>W401</fpage>
    <lpage>W407</lpage>
    <history>
      <date date-type="accepted">
        <day>29</day>
        <month>4</month>
        <year>2014</year>
      </date>
      <date date-type="rev-recd">
        <day>07</day>
        <month>4</month>
        <year>2014</year>
      </date>
      <date date-type="received">
        <day>31</day>
        <month>1</month>
        <year>2014</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2014. Published by Oxford University
                    Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2014</copyright-year>
      <license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/3.0/">
        <license-p>This is an Open Access article distributed under the terms of the
                        Creative Commons Attribution License (<uri xlink:type="simple" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</uri>), which permits
                        unrestricted reuse, distribution, and reproduction in any medium, provided
                        the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:title="pdf" xlink:type="simple" xlink:href="gku410.pdf"/>
    <abstract>
      <p>Major advances in genome editing have recently been made possible with the
                    development of the TALEN and CRISPR/Cas9 methods. The speed and ease of
                    implementing these technologies has led to an explosion of mutant and transgenic
                    organisms. A rate-limiting step in efficiently applying TALEN and CRISPR/Cas9
                    methods is the selection and design of targeting constructs. We have developed
                    an online tool, CHOPCHOP (<ext-link ext-link-type="uri" xlink:href="https://chopchop.rc.fas.harvard.edu">https://chopchop.rc.fas.harvard.edu</ext-link>), to expedite the design
                    process. CHOPCHOP accepts a wide range of inputs (gene identifiers, genomic
                    regions or pasted sequences) and provides an array of advanced options for
                    target selection. It uses efficient sequence alignment algorithms to minimize
                    search times, and rigorously predicts off-target binding of single-guide RNAs
                    (sgRNAs) and TALENs. Each query produces an interactive visualization of the
                    gene with candidate target sites displayed at their genomic positions and
                    color-coded according to quality scores. In addition, for each possible target
                    site, restriction sites and primer candidates are visualized, facilitating a
                    streamlined pipeline of mutant generation and validation. The ease-of-use and
                    speed of CHOPCHOP make it a valuable tool for genome engineering.</p>
    </abstract>
    <counts>
      <page-count count="7"/>
    </counts>
    <custom-meta-group>
      <custom-meta>
        <meta-name>cover-date</meta-name>
        <meta-value>1 July 2014</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="sec1">
    <title>INTRODUCTION</title>
    <p>The discovery of numerous bacterial nucleic acid modification systems has led to the
                recent development of two modular, precise genome editing tools (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>). The TALE
                (transcription activator-like effector) and CRISPR/Cas (clustered regularly
                interspaced short palindromic repeats) systems have recently been optimized for
                research use to site-specifically introduce mutations and manipulate transcriptional
                activation and repression in a variety of organisms (<xref rid="B3" ref-type="bibr">3–7</xref>). </p>
    <p>TALENs are a genome editing method derived from plant pathogenic bacteria (<xref rid="B2" ref-type="bibr">2</xref>). TALE architecture is composed of three
                parts: an N-terminal domain, TALE repeat domains, and a C-terminal domain. The TALE
                repeat domains typically consist of 34 amino acid residues, where the 12th and 13th
                repeat variable di-residues (RVDs) determine DNA nucleotide binding specificity
                    (<xref rid="B8" ref-type="bibr">8</xref><xref rid="B9" ref-type="bibr">9</xref>). Each RVD recognizes a specific nucleotide, leading to a simple code for
                DNA recognition: NI for adenine, HD for cytosine, NG for thymine and NH or NN for
                guanine (<xref rid="B8" ref-type="bibr">8–11</xref>). Importantly, the RVDs
                can be assembled sequentially to bind any given target sequence. For genome editing
                purposes, TALEs are fused to the <italic>FokI</italic> nuclease domain to create
                TALE nucleases (TALENs). Because <italic>FokI</italic> only cleaves as a dimer,
                sites must be targeted by a pair of TALENs binding on opposite faces of the DNA
                strand, spaced ∼14–20 bp apart. The <italic>FokI</italic> nuclease
                domains dimerize across the spacer sequence and create a double-strand break (DSB).
                The DSB can be repaired through error-prone non-homologous end-joining (NHEJ), which
                often results in indels and potentially frameshift mutations. For efficient binding,
                TALEN target sequences require a thymine at the 5′ end for recognition by
                the TALE N-terminus (<xref rid="B3" ref-type="bibr">3</xref><xref rid="B8" ref-type="bibr">8,9</xref>).</p>
    <p>The CRISPR/Cas9 system originates from a bacterial immune system that has been
                adopted for use as a programmable genome editing tool. <italic>Streptococcus
                    pyogenes</italic> Cas9 nuclease is directed to target sites in the genome by a
                single-guide RNA (sgRNA) (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B12" ref-type="bibr">12</xref>). The
                Cas9/sgRNA complex binds a 20 bp target sequence followed by a 3 bp protospacer
                adjacent motif (PAM) -NGG (two invariable Gs preceded by a variable base), and it
                creates a DSB that is repaired in a seemingly identical manner to TALEN-induced
                DSBs. While the presence of an -NGG PAM motif is one of the few requirements for
                binding, the methods used to generate sgRNAs for targeting often impose additional
                restrictions. Depending on the polymerase used for sgRNA synthesis, the 5′
                end dinucleotides may be limited to, for example, 5′ GN- for the commonly
                used U6 promoter (polymerase III), or 5′ GG- for T7 polymerase (<xref rid="B4" ref-type="bibr">4,5</xref>,<xref rid="B13" ref-type="bibr">13</xref>).
                In addition, certain criteria such as guanine-cytosine content (GC-content) appear
                to influence binding efficiency (<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>). These, along with other guidelines to
                ensure target suitability, have been used to mostly manually design sgRNAs to
                generate mutations and knockouts in a variety of organisms including bacteria,
                yeast, zebrafish, <italic>Xenopus</italic>, nematodes, fruit flies, mice and human
                cells (<xref rid="B4" ref-type="bibr">4,5</xref>,<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B16" ref-type="bibr">16–22</xref>).</p>
    <p>TALEN and sgRNA design requires identification of target sites that fulfill certain
                sequence requirements while simultaneously avoiding off-targets elsewhere in the
                genome. Several studies have demonstrated the limited specificity of TALEN- and
                particularly Cas9-based genome editing strategies, highlighting the importance of
                determining the uniqueness of each candidate target site (<xref rid="B3" ref-type="bibr">3</xref><xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B23" ref-type="bibr">23–27</xref>). Existing tools for identifying TALEN or
                sgRNA target sites (<xref rid="B25" ref-type="bibr">25</xref><xref rid="B28" ref-type="bibr">,28-34</xref>) have limitations, including acceptance of few
                input formats, slow search times, restriction to either TALEN or CRISPR/Cas9 target
                design, minimal or no visualization of the target locus and/or limited information
                about potential off-target sites (Supplementary Table S1).</p>
    <p>We have developed CHOPCHOP, a web-based tool that allows users to easily and rapidly
                select the optimal TALEN or CRISPR/Cas9 target sequences in genes from a variety of
                organisms. To overcome limitations of previous tools, CHOPCHOP accepts a wide range
                of inputs, employs rigorous off-target search algorithms to predict the specificity
                of each target site in the genome (<xref rid="B35" ref-type="bibr">35</xref>), and
                displays all options in an interactive graphical interface. In addition, to expedite
                the validation process, CHOPCHOP designs target site-specific primers for polymerase
                chain reaction (PCR) and displays them together with restriction sites in the gene
                context.</p>
  </sec>
  <sec sec-type="materials|methods" id="sec2">
    <title>MATERIALS AND METHODS</title>
    <sec id="sec2-1">
      <title>Target sequence</title>
      <p>CHOPCHOP accepts three forms of input: gene name, genomic coordinates or DNA
                    sequence. If the user provides a gene name, CHOPCHOP converts it to genomic
                    coordinates in the relevant organism by consulting gene tables from a variety of
                    sources (e.g. University of California Santa Cruz (UCSC) Genome Browser (<xref rid="B36" ref-type="bibr">36</xref>)). If the user provides genomic
                    coordinates, for instance to target an intron, these coordinates (or coordinates
                    from the gene table) are parsed by TwoBitToFa (<xref rid="B36" ref-type="bibr">36</xref>), which retrieves the DNA sequence corresponding to the genomic
                    region. If the user provides direct DNA sequence, this sequence (or sequence
                    from TwoBitToFa) is scanned for all potential target sites fulfilling the
                    sequence requirements for the current search (as decided by the user).</p>
    </sec>
    <sec id="Sec2-2">
      <title>Search for off-targets</title>
      <p>The candidate target sites are mapped by Bowtie (<xref rid="B35" ref-type="bibr">35</xref>) with the appropriate number of mismatches (‘-v’
                    mode according to the user-specified options) in a sub-region of the target site
                    where appropriate (‘-L’ seed mode). In TALEN mode, two target
                    sites are paired if they are within a specified range determined by the user.
                    Each sgRNA or TALEN pair is then ranked according to: (i) the number of
                    off-targets in the genome (TALEN mode considers individual off-targets and
                    paired off-targets), and (ii) how many mismatches lie within the off-targets. In
                    addition, for CRISPR/Cas9 mode, the results are ranked by: (iii) GC-content, and
                    (iv) the presence of a guanine at position 20 in the sgRNA target site (<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>). Any target sites with the same score are then sorted by their
                    position in the gene (with preference to 5′ positions). The specific
                    metrics employed by CHOPCHOP are listed on the site under
                    ‘Scoring’. These are updated with new findings from the
                    literature. TALEN results are clustered and suppressed to avoid the display of
                    multiple equivalent TALENs on the results page (e.g. differing by only the size
                    of the spacer sequence). The TALEN pair with the highest ranking in each cluster
                    is displayed on the results page.</p>
    </sec>
    <sec id="sec2-3">
      <title>Visualization</title>
      <p>Interactive visualization is produced by the D3 JavaScript library (<xref rid="B37" ref-type="bibr">37</xref>). The targeted gene or locus is
                    displayed in a zoomable interface, with each sgRNA or TALEN pair displayed at
                    its appropriate location. Clicking on any individual sgRNA/TALEN target site
                    results in a detailed view displaying candidate primer pairs flanking the
                    selected target region and restriction sites.</p>
    </sec>
    <sec id="sec2-4">
      <title>Primer design</title>
      <p>Primer pairs spanning the target site are designed by the batch version of
                    Primer3 (<xref rid="B38" ref-type="bibr">38</xref>) using user-specified
                    options. The default parameters are primers of size 18–25 bp (optimum:
                    22 bp), a product size of 150–290 bp, and a primer
                        <italic>T</italic><sub>m</sub> of 57–63°C (optimum:
                    60°C). The primers are then mapped to the rest of the genome by Bowtie
                        (<xref rid="B35" ref-type="bibr">35</xref>) (options ‘-v 0
                    –best –k 10’), and subsequently ranked according to
                    their specificity.</p>
    </sec>
  </sec>
  <sec sec-type="results" id="sec3">
    <title>RESULTS</title>
    <sec id="sec3-1">
      <title>CHOPCHOP web tool</title>
      <p>CHOPCHOP is an easy-to-use web tool that maximizes user flexibility while
                    maintaining a simple and interactive interface. CHOPCHOP can be run in either
                    CRISPR/Cas9 mode or TALEN mode. It runs with default parameters, but accepts a
                    range of advanced options for more refined searches. CHOPCHOP employs a powerful
                    system for finding off-target sites, and displays the output in an interactive
                    table and within the gene architecture. CHOPCHOP also carries out automated
                    primer design to aid with downstream genotyping steps.</p>
    </sec>
    <sec id="sec3-2">
      <title>Implementation</title>
      <sec id="sec3-2-1">
        <title>Input</title>
        <p>CHOPCHOP can be run with as few as three basic input options, or with
                        additional advanced parameters. The basic input comprises: (i) a gene name
                        (accepting RefSeq, ENSEMBL, FlyBase and WormBase gene IDs), genomic
                        coordinates or a pasted sequence; (ii) a growing list of organisms
                            (<italic>Homo sapiens</italic>, <italic>Mus musculus</italic>,
                            <italic>Danio rerio</italic>, <italic>Drosophila melanogaster</italic>,
                            <italic>Caenorhabditis elegans</italic>, <italic>Saccharomyces
                            cerevisiae</italic>, <italic>Arabidopsis thaliana</italic>,
                            <italic>Xenopus tropicalis</italic>, <italic>Rattus</italic>
                        <italic>norvegicus, Gallus gallus, Oryzias latipes</italic>,
                            <italic>Gasterosteus aculeatus</italic> and <italic>Anopheles
                            gambiae</italic>); and (iii) the choice between CRISPR/Cas9 or TALEN
                        mode (Figure <xref ref-type="fig" rid="f1">1</xref>). The advanced options
                        allow the user to target a sub-region of the gene, such as the 5′
                        UTR, 3′ UTR, splice sites, full exons (including UTRs), or a
                        specified subset of exons.</p>
        <fig id="f1" position="float">
          <label>Figure 1.</label>
          <caption>
            <p>Workflow of a CHOPCHOP CRISPR/Cas9 query. The home page of CHOPCHOP
                                allows users to enter a gene name, genomic coordinates or a DNA
                                sequence, and select an organism and TALEN or CRISPR/Cas9 mode.
                                Advanced options can be toggled. The main results page presents the
                                sgRNA or TALEN target sites within the gene architecture (exon,
                                blue; intron, red), with each option color-coded according to
                                ranking. Hovering over an entry in the table highlights the
                                corresponding graphical sgRNA/TALEN and vice versa. Clicking on a
                                specific result takes the user to a page containing the zoomed in
                                locus with the predicted cut site highlighted in red, primer options
                                in purple and restriction sites color-coded according to whether
                                they are unique in the region.</p>
          </caption>
          <graphic xlink:href="gku410fig1"/>
        </fig>
        <p>The CRISPR/Cas9 search mode locates 23 bp target sites including the PAM
                        motif. The user may restrict this search to only target sites suited for
                        synthesis using a particular polymerase, e.g. GG- or GN-/NG- at the
                        5′ end of the sgRNA. Recent reports have shown that Cas9 can have
                        substantial off-target activity in the genome (<xref rid="B23" ref-type="bibr">23–26</xref>) and that tolerance to mismatches
                        shows significant variance depending on the position within the sgRNA (<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B25" ref-type="bibr">25</xref>). Another study demonstrated that the number of mismatches
                        tolerated is dependent upon the specific sgRNA (<xref rid="B23" ref-type="bibr">23</xref>), suggesting there is no universal rule for
                        CRISPR/Cas9 sgRNA off-target prediction. For this reason, CHOPCHOP offers
                        the choice between a variety of published methods for off-target prediction.
                        (i) One study found mismatches were tolerated at any position except within
                        the PAM motif (<xref rid="B25" ref-type="bibr">25</xref>). CHOPCHOP provides
                        a search mode reflecting this rule, searching for mismatches across all
                        bases upstream of the PAM. This is the default mode. (ii) An alternative
                        study found that single-base mismatches up to 11 bp 5′ of the PAM
                        completely abolished cleavage by Cas9 (<xref rid="B4" ref-type="bibr">4</xref>). In contrast, mutations further upstream of the PAM retained
                        cleavage activity. CHOPCHOP therefore provides an alternative search mode
                        that locates off-targets with mismatches only in the region where a mismatch
                        would still induce cleavage. (iii) Finally, CHOPCHOP provides a fast mode
                        that only searches for perfect matches of the sgRNA target sequence across
                        the genome.</p>
        <p>The TALEN search mode locates pairs of target sites on opposite strands,
                        separated by a 14–20 bp spacer sequence, with the requirement that
                        both sites have a T at the 5′ end. The TALEN-specific options allow
                        the user to cater the target search to a particular TALEN architecture by
                        changing the length of the spacer sequence and the length of the target
                        sites. In addition, depending upon the assembly kit being used, the user can
                        choose to use either the RVD ‘NN’ for guanines, or
                        ‘NH’, which has been shown to bind guanines more
                        specifically than ‘NN’ (<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B11" ref-type="bibr">11</xref>). TALEN off-target
                        binding does not appear to have the same position-specific complexity as
                        CRISPR/Cas9 sgRNAs, therefore the TALEN off-target method searches for
                        off-targets with 0, 1 or 2 mismatches across each site. The default method
                        searches for two mismatches.</p>
        <p>In order to analyze whether Cas9 or TALENs have successfully cleaved the
                        target locus, users may need to amplify the region of interest for further
                        analysis by methods such as deep sequencing or a T7E1 assay (<xref rid="B39" ref-type="bibr">39</xref>). CHOPCHOP therefore integrates primer design
                        with sgRNA/TALEN target site design using Primer3 (<xref rid="B38" ref-type="bibr">38</xref>). Primers are designed to amplify the region
                        surrounding the cut site, and mapped against the genome to avoid off-targets
                        producing amplicons of similar length. In the advanced options, the user can
                        adjust the primer specifications, including amplicon size, primer
                            <italic>T</italic><sub>m</sub>, primer length and the minimum distance
                        between each primer and the target site. In addition, some users might
                        prefer to assess successful mutagenesis using restriction enzyme digestion.
                        CHOPCHOP allows the user to select restriction sites from a particular
                        restriction enzyme company, and it allows the user to specify the minimum
                        size of the restriction site.</p>
      </sec>
      <sec id="sec3-2-2">
        <title>Output</title>
        <p>The majority of CHOPCHOP queries are executed within a matter of seconds, and
                        the results displayed in an interactive table and interactive gene model.
                        CHOPCHOP ranks the search results according to a number of criteria. Both
                        the TALEN and CRISPR/Cas9 modes are ranked by: (i) the number of
                        off-targets, (ii) whether the off-targets contain mismatches or are perfect
                        hits, and (iii) where the target site lies within the architecture of the
                        gene (many users wish to create a frameshift/null mutation and therefore
                        will prefer a mutation at the 5′ end of the gene). Additionally, for
                        CRISPR/Cas9 mode the results are ranked by (iv) GC-content. Recent reports
                        suggest that sgRNAs are most effective with a GC-content between 45 and 80%,
                        and (v) a guanine at position 20 in the target site, which is associated
                        with improved activity (<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>). For TALEN mode, off-targets are
                        specifically scored by whether an individual TALEN target site occurs
                        elsewhere in the genome, or whether both members of a pair lie within
                        cutting distance of one another at an off-target location. For both
                        CRISPR/Cas9 and TALEN mode, the results table provides the sequence of the
                        target site, its ranking, genomic location (including exons and orientation)
                        and the number of potential off-targets with 0, 1 or 2 mismatches (Figure
                            <xref ref-type="fig" rid="f1">1</xref>). The CRISPR/Cas9 mode also
                        provides the GC-content of the sgRNA target site, and the TALEN mode
                        provides restriction sites that lie in the spacer between two TALENs, as
                        well as the RVDs that should be synthesized for the target site. CHOPCHOP
                        also provides an interactive graphical representation of the gene, with each
                        sgRNA or TALEN target site color-coded according to ranking (Figure <xref ref-type="fig" rid="f1">1</xref>). This allows users to inspect
                        candidate targets by their location within the gene as well as their
                        specificity within the genome as a whole. The graphical output is generated
                        using the D3 JavaScript library (<xref rid="B37" ref-type="bibr">37</xref>)
                        and enables the user to zoom and scroll across the gene. Finally, users can
                        download a text file containing the search results, as well as a GenBank
                        file of the DNA sequence annotated with the target sites, either with or
                        without introns.</p>
        <p>Individual target sites can be inspected in a separate detailed view,
                        displaying additional information about the genomic location of off-targets,
                        and the location of the mismatches within the off-target sites (Figure <xref ref-type="fig" rid="f2">2</xref>). Upon zooming within this specific
                        region, the DNA sequence becomes visible. For TALENs, the gene view
                        suppresses the visibility of substantially overlapping TALEN pairs to avoid
                        redundancy. In the detailed view, however, all of the clustered targets are
                        listed, should the user prefer a different target sequence in the same
                        approximate location. The detailed view also presents the user with all the
                        restriction sites in the surrounding region that can be used for testing
                        cleavage activity. Restriction sites are color-coded according to whether
                        they are unique within the region. Finally, the detailed view displays
                        primer pairs that flank the target site, and a downloadable GenBank file of
                        the targeted region is available, containing annotations of the target site
                        and primer designs.</p>
        <fig id="f2" position="float">
          <label>Figure 2.</label>
          <caption>
            <p>CHOPCHOP provides detailed information about each CRISPR/Cas9 and
                                TALEN target site. (<bold>A</bold>) The detailed information page
                                provides a zoomed in view of the target locus with visible DNA
                                sequence, primer options (above the gene, purple) and restriction
                                sites (below the gene; green if unique in the region, red if not).
                                In TALEN mode the target site is color-coded; TALEN 1 is blue, the
                                spacer is black and TALEN 2 is red. (<bold>B</bold>) Information is
                                provided about predicted off-targets: the genomic location, number
                                of mismatches and location of mismatches within the sequence.
                                    (<bold>C</bold>) Information is provided about
                                the primer designs, including the primer sequence,
                                    <italic>T</italic><sub>m</sub> and product size.</p>
          </caption>
          <graphic xlink:href="gku410fig2"/>
        </fig>
      </sec>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="sec4">
    <title>CONCLUSION</title>
    <p>CHOPCHOP is a user-friendly web tool that locates optimal CRISPR/Cas9 and TALEN
                target sites for any genomic region, and presents the information in an interactive
                and intuitive manner. CHOPCHOP expedites the design process for CRISPR/Cas9- or
                TALEN-based mutations with fast run times, powerful off-target prediction and
                integrated primer design.</p>
    <p>CHOPCHOP has a number of features that separate it from the other CRISPR/Cas9 or
                TALEN tools currently available (Supplementary Table S1) (<xref rid="B25" ref-type="bibr">25</xref><xref rid="B28" ref-type="bibr">,28-34</xref>). First,
                CHOPCHOP accepts a wide range of inputs - gene identifiers, genomic regions or
                pasted sequences - making it suitable for a broad range of uses. Second, CHOPCHOP
                provides a dynamic graphical output display that includes an interactive
                visualization of the gene, with each Cas9/TALEN target site displayed at its genomic
                position and color-coded according to its quality. The visualization of all possible
                target sites in the gene model makes the selection of the optimal candidate easy,
                and is an ideal system for the design of two sgRNAs, as used in the increasingly
                popular dual nickase approach (<xref rid="B40" ref-type="bibr">40</xref>). Third,
                unlike most tools, CHOPCHOP integrates TALEN and CRISPR/Cas9 target design into a
                single tool. Fourth, CHOPCHOP provides automatic primer generation and restriction
                site visualization for genotyping. Finally, CHOPCHOP provides downloadable results,
                including a GenBank file with annotations of the gene's exons, introns and target
                sites, and a GenBank file of the specific target region with primer designs.
                CHOPCHOP creates a streamlined process from start to end of mutant design, and is a
                valuable new resource for genome editing technologies.</p>
  </sec>
  <sec sec-type="supplementary-material" id="sec5">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link ext-link-type="uri" xlink:href="http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gku410/-/DC1">Supplementary Data</ext-link> are available at NAR Online.</p>
    <supplementary-material id="PMC_1" content-type="local-data">
      <caption>
        <title>Supplementary Data</title>
      </caption>
      <media mimetype="text" mime-subtype="html" xlink:href="supp_42_W1_W401__index.html"/>
      <media xlink:role="associated-file" mimetype="application" mime-subtype="msword" xlink:href="supp_gku410_nar-00284-web-b-2014-File004.doc"/>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack>
    <title>ACKNOWLEDGMENTS</title>
    <p>We would like to thank Alex Schier and Michele Clamp for support, and the many users
                who provided helpful suggestions for improving CHOPCHOP and this manuscript, in
                particular: G.-L. Chew, P. Eimon, A. Pauli, F. Imam, N. Lawson, C. Lengner, T.J.
                Moff, T.T. Montague, P. Müller, O. Randlett and E. Wang. T.G.M. and J.M.C.
                would also like to thank the staff of CS50 for their excellent teaching and the
                opportunity to begin this project.</p>
  </ack>
  <sec id="sec6">
    <title>FUNDING</title>
    <p>National Defense Science and Engineering Graduate Fellowship (to T.G.M.); American
                Cancer Society (to J.A.G.); Human Frontier Science Program (to E.V.); National Human
                Genome Research Institute (NHGRI) Center for Excellence in Genomics Science [P50
                HG005550 to J.M.C. and G.M.C.]. Funding for open access charge: NHGRI Center for
                Excellence in Genomics Science [P50 HG005550 to J.M.C. and G.M.C.].</p>
    <p><italic>Conflict of interest statement</italic>. G.M. Church serves as founder and
                active advisor of Editas and Egenesis Bio, and also serves as advisor for Caribou
                Biosciences, all of which perform active research on Cas9 applications. Please see
                    <ext-link ext-link-type="uri" xlink:href="http://arep.med.harvard.edu/gmc/tech.html">http://arep.med.harvard.edu/gmc/tech.html</ext-link> for more information.</p>
  </sec>
  <ref-list>
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mali</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Esvelt</surname>
            <given-names>K.M.</given-names>
          </name>
          <name>
            <surname>Church</surname>
            <given-names>G.M.</given-names>
          </name>
        </person-group>
        <article-title>Cas9 as a versatile tool for engineering biology</article-title>
        <source>Nat. Methods</source>
        <year>2013</year>
        <volume>10</volume>
        <fpage>957</fpage>
        <lpage>963</lpage>
        <pub-id pub-id-type="pmid">24076990</pub-id>
      </element-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gaj</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Gersbach</surname>
            <given-names>C.A.</given-names>
          </name>
          <name>
            <surname>Barbas</surname>
            <given-names>C.F.</given-names>
            <suffix>III</suffix>
          </name>
        </person-group>
        <article-title>ZFN, TALEN, and CRISPR/Cas-based methods for genome
                        engineering</article-title>
        <article-title>Trends Biotechnol.</article-title>
        <year>2013</year>
        <volume>31</volume>
        <fpage>397</fpage>
        <lpage>405</lpage>
      </element-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Miller</surname>
            <given-names>J.C.</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Qiao</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Barlow</surname>
            <given-names>K.A.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Xia</surname>
            <given-names>D.F.</given-names>
          </name>
          <name>
            <surname>Meng</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Paschon</surname>
            <given-names>D.E.</given-names>
          </name>
          <name>
            <surname>Leung</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Hinkley</surname>
            <given-names>S.J.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A TALE nuclease architecture for efficient genome
                        editing</article-title>
        <source>Nat. Biotechnol.</source>
        <year>2011</year>
        <volume>29</volume>
        <fpage>143</fpage>
        <lpage>148</lpage>
        <pub-id pub-id-type="pmid">21179091</pub-id>
      </element-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cong</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Ran</surname>
            <given-names>F.A.</given-names>
          </name>
          <name>
            <surname>Cox</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Barretto</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Habib</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Hsu</surname>
            <given-names>P.D.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Marraffini</surname>
            <given-names>L.A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Multiplex genome engineering using CRISPR/Cas
                        systems</article-title>
        <source>Science</source>
        <year>2013</year>
        <volume>339</volume>
        <fpage>819</fpage>
        <lpage>823</lpage>
        <pub-id pub-id-type="pmid">23287718</pub-id>
      </element-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mali</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Esvelt</surname>
            <given-names>K.M.</given-names>
          </name>
          <name>
            <surname>Aach</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Guell</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>DiCarlo</surname>
            <given-names>J.E.</given-names>
          </name>
          <name>
            <surname>Norville</surname>
            <given-names>J.E.</given-names>
          </name>
          <name>
            <surname>Church</surname>
            <given-names>G.M.</given-names>
          </name>
        </person-group>
        <article-title>RNA-guided human genome engineering via Cas9</article-title>
        <source>Science</source>
        <year>2013</year>
        <volume>339</volume>
        <fpage>823</fpage>
        <lpage>826</lpage>
        <pub-id pub-id-type="pmid">23287722</pub-id>
      </element-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mali</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Aach</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Stranges</surname>
            <given-names>P.B.</given-names>
          </name>
          <name>
            <surname>Esvelt</surname>
            <given-names>K.M.</given-names>
          </name>
          <name>
            <surname>Moosburner</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Kosuri</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Church</surname>
            <given-names>G.M.</given-names>
          </name>
        </person-group>
        <article-title>CAS9 transcriptional activators for target specificity screening
                        and paired nickases for cooperative genome engineering</article-title>
        <source>Nat. Biotechnol.</source>
        <year>2013</year>
        <volume>31</volume>
        <fpage>833</fpage>
        <lpage>838</lpage>
        <pub-id pub-id-type="pmid">23907171</pub-id>
      </element-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bikard</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Samai</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Hochschild</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Marraffini</surname>
            <given-names>L.A.</given-names>
          </name>
        </person-group>
        <article-title>Programmable repression and activation of bacterial gene
                        expression using an engineered CRISPR-Cas system</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2013</year>
        <volume>41</volume>
        <fpage>7429</fpage>
        <lpage>7437</lpage>
        <pub-id pub-id-type="pmid">23761437</pub-id>
      </element-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Boch</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Scholze</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Schornack</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Landgraf</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Hahn</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Kay</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Lahaye</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Nickstadt</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Bonas</surname>
            <given-names>U.</given-names>
          </name>
        </person-group>
        <article-title>Breaking the code of DNA binding specificity of TAL-type III
                        effectors</article-title>
        <source>Science</source>
        <year>2009</year>
        <volume>326</volume>
        <fpage>1509</fpage>
        <lpage>1512</lpage>
        <pub-id pub-id-type="pmid">19933107</pub-id>
      </element-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moscou</surname>
            <given-names>M.J.</given-names>
          </name>
          <name>
            <surname>Bogdanove</surname>
            <given-names>A.J.</given-names>
          </name>
        </person-group>
        <article-title>A simple cipher governs DNA recognition by TAL
                        effectors</article-title>
        <source>Science</source>
        <year>2009</year>
        <volume>326</volume>
        <fpage>1501</fpage>
        <pub-id pub-id-type="pmid">19933106</pub-id>
      </element-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Streubel</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Blücher</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Landgraf</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Boch</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>TAL effector RVD specificities and efficiencies</article-title>
        <source>Nat. Biotechnol.</source>
        <year>2012</year>
        <volume>30</volume>
        <fpage>593</fpage>
        <lpage>595</lpage>
        <pub-id pub-id-type="pmid">22781676</pub-id>
      </element-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cong</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Kuo</surname>
            <given-names>Y.-C.</given-names>
          </name>
          <name>
            <surname>Cunniff</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>F.</given-names>
          </name>
        </person-group>
        <article-title>Comprehensive interrogation of natural TALE DNA-binding modules
                        and transcriptional repressor domains</article-title>
        <source>Nat. Commun.</source>
        <year>2012</year>
        <volume>3</volume>
        <fpage>968</fpage>
        <pub-id pub-id-type="pmid">22828628</pub-id>
      </element-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jinek</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Chylinski</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Fonfara</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Hauer</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Doudna</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Charpentier</surname>
            <given-names>E.</given-names>
          </name>
        </person-group>
        <article-title>A programmable dual-RNA-guided DNA endonuclease in adaptive
                        bacterial immunity</article-title>
        <source>Science</source>
        <year>2012</year>
        <volume>337</volume>
        <fpage>816</fpage>
        <lpage>821</lpage>
        <pub-id pub-id-type="pmid">22745249</pub-id>
      </element-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hwang</surname>
            <given-names>W.Y.</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Reyon</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Maeder</surname>
            <given-names>M.L.</given-names>
          </name>
          <name>
            <surname>Tsai</surname>
            <given-names>S.Q.</given-names>
          </name>
          <name>
            <surname>Sander</surname>
            <given-names>J.D.</given-names>
          </name>
          <name>
            <surname>Peterson</surname>
            <given-names>R.T.</given-names>
          </name>
          <name>
            <surname>Yeh</surname>
            <given-names>J.-R.J.</given-names>
          </name>
          <name>
            <surname>Joung</surname>
            <given-names>J.K.</given-names>
          </name>
        </person-group>
        <article-title>Efficient genome editing in zebrafish using a CRISPR-Cas
                        system</article-title>
        <source>Nat. Biotechnol.</source>
        <year>2013</year>
        <volume>31</volume>
        <fpage>227</fpage>
        <lpage>229</lpage>
        <pub-id pub-id-type="pmid">23360964</pub-id>
      </element-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>J.J.</given-names>
          </name>
          <name>
            <surname>Sabatini</surname>
            <given-names>D.M.</given-names>
          </name>
          <name>
            <surname>Lander</surname>
            <given-names>E.S.</given-names>
          </name>
        </person-group>
        <article-title>Genetic screens in human cells using the CRISPR-Cas9
                        system</article-title>
        <source>Science</source>
        <year>2014</year>
        <volume>343</volume>
        <fpage>80</fpage>
        <lpage>84</lpage>
        <pub-id pub-id-type="pmid">24336569</pub-id>
      </element-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gagnon</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Valen</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Thyme</surname>
            <given-names>S.B.</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Ahkmetova</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Pauli</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Montague</surname>
            <given-names>T.G.</given-names>
          </name>
          <name>
            <surname>Zimmerman</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Richter</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Schier</surname>
            <given-names>A.F.</given-names>
          </name>
        </person-group>
        <article-title>Efficient mutagenesis by Cas9 protein-mediated oligonucleotide
                        insertion and large-scale assessment of single-guide RNAs</article-title>
        <article-title>PLoS ONE</article-title>
        <year>2014</year>
        <volume>9</volume>
        <fpage>e98186</fpage>
      </element-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Bikard</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Cox</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Marraffini</surname>
            <given-names>L.A.</given-names>
          </name>
        </person-group>
        <article-title>RNA-guided editing of bacterial genomes using CRISPR-Cas
                        systems</article-title>
        <source>Nat. Biotechnol.</source>
        <year>2013</year>
        <volume>31</volume>
        <fpage>233</fpage>
        <lpage>239</lpage>
        <pub-id pub-id-type="pmid">23360965</pub-id>
      </element-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>DiCarlo</surname>
            <given-names>J.E.</given-names>
          </name>
          <name>
            <surname>Norville</surname>
            <given-names>J.E.</given-names>
          </name>
          <name>
            <surname>Mali</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Rios</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Aach</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Church</surname>
            <given-names>G.M.</given-names>
          </name>
        </person-group>
        <article-title>Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas
                        systems</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2013</year>
        <volume>41</volume>
        <fpage>4336</fpage>
        <lpage>4343</lpage>
        <pub-id pub-id-type="pmid">23460208</pub-id>
      </element-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gratz</surname>
            <given-names>S.J.</given-names>
          </name>
          <name>
            <surname>Cummings</surname>
            <given-names>A.M.</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>J.N.</given-names>
          </name>
          <name>
            <surname>Hamm</surname>
            <given-names>D.C.</given-names>
          </name>
          <name>
            <surname>Donohue</surname>
            <given-names>L.K.</given-names>
          </name>
          <name>
            <surname>Harrison</surname>
            <given-names>M.M.</given-names>
          </name>
          <name>
            <surname>Wildonger</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>O'Connor-Giles</surname>
            <given-names>K.M.</given-names>
          </name>
        </person-group>
        <article-title>Genome engineering of Drosophila with the CRISPR RNA-guided Cas9
                        nuclease</article-title>
        <source>Genetics</source>
        <year>2013</year>
        <volume>194</volume>
        <fpage>1029</fpage>
        <lpage>1035</lpage>
        <pub-id pub-id-type="pmid">23709638</pub-id>
      </element-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Friedland</surname>
            <given-names>A.E.</given-names>
          </name>
          <name>
            <surname>Tzur</surname>
            <given-names>Y.B.</given-names>
          </name>
          <name>
            <surname>Esvelt</surname>
            <given-names>K.M.</given-names>
          </name>
          <name>
            <surname>Colaiácovo</surname>
            <given-names>M.P.</given-names>
          </name>
          <name>
            <surname>Church</surname>
            <given-names>G.M.</given-names>
          </name>
          <name>
            <surname>Calarco</surname>
            <given-names>J.A.</given-names>
          </name>
        </person-group>
        <article-title>Heritable genome editing in C. elegans via a CRISPR-Cas9
                        system</article-title>
        <article-title>Nat. Methods</article-title>
        <year>2013</year>
        <volume>10</volume>
        <fpage>741</fpage>
        <lpage>743</lpage>
      </element-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Shivalila</surname>
            <given-names>C.S.</given-names>
          </name>
          <name>
            <surname>Dawlaty</surname>
            <given-names>M.M.</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>A.W.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Jaenisch</surname>
            <given-names>R.</given-names>
          </name>
        </person-group>
        <article-title>One-step generation of mice carrying mutations in multiple genes
                        by CRISPR/Cas-mediated genome engineering</article-title>
        <source>Cell</source>
        <year>2013</year>
        <volume>153</volume>
        <fpage>910</fpage>
        <lpage>918</lpage>
        <pub-id pub-id-type="pmid">23643243</pub-id>
      </element-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nakayama</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Fish</surname>
            <given-names>M.B.</given-names>
          </name>
          <name>
            <surname>Fisher</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Oomen-Hajagos</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Thomsen</surname>
            <given-names>G.H.</given-names>
          </name>
          <name>
            <surname>Grainger</surname>
            <given-names>R.M.</given-names>
          </name>
        </person-group>
        <article-title>Simple and efficient CRISPR/Cas9-mediated targeted mutagenesis in
                        Xenopus tropicalis</article-title>
        <article-title>Genesis</article-title>
        <year>2013</year>
        <volume>51</volume>
        <fpage>835</fpage>
        <lpage>843</lpage>
      </element-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Blitz</surname>
            <given-names>I.L.</given-names>
          </name>
          <name>
            <surname>Biesinger</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Cho</surname>
            <given-names>K.W.Y.</given-names>
          </name>
        </person-group>
        <article-title>Biallelic genome modification in F0 Xenopus tropicalis embryos
                        using the CRISPR/Cas system</article-title>
        <source>Genesis</source>
        <year>2013</year>
        <volume>51</volume>
        <fpage>827</fpage>
        <lpage>834</lpage>
        <pub-id pub-id-type="pmid">24123579</pub-id>
      </element-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fu</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Foden</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Khayter</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Maeder</surname>
            <given-names>M.L.</given-names>
          </name>
          <name>
            <surname>Reyon</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Joung</surname>
            <given-names>J.K.</given-names>
          </name>
          <name>
            <surname>Sander</surname>
            <given-names>J.D.</given-names>
          </name>
        </person-group>
        <article-title>High-frequency off-target mutagenesis induced by CRISPR-Cas
                        nucleases in human cells</article-title>
        <article-title>Nat. Biotechnol.</article-title>
        <year>2013</year>
        <volume>31</volume>
        <fpage>822</fpage>
        <lpage>826</lpage>
      </element-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pattanayak</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Guilinger</surname>
            <given-names>J.P.</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Doudna</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>D.R.</given-names>
          </name>
        </person-group>
        <article-title>High-throughput profiling of off-target DNA cleavage reveals
                        RNA-programmed Cas9 nuclease specificity</article-title>
        <source>Nat. Biotechnol.</source>
        <year>2013</year>
        <volume>31</volume>
        <fpage>839</fpage>
        <lpage>843</lpage>
        <pub-id pub-id-type="pmid">23934178</pub-id>
      </element-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hsu</surname>
            <given-names>P.D.</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>D.A.</given-names>
          </name>
          <name>
            <surname>Weinstein</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Ran</surname>
            <given-names>F.A.</given-names>
          </name>
          <name>
            <surname>Konermann</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Agarwala</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Fine</surname>
            <given-names>E.J.</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Shalem</surname>
            <given-names>O.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DNA targeting specificity of RNA-guided Cas9
                        nucleases</article-title>
        <source>Nat. Biotechnol.</source>
        <year>2013</year>
        <volume>31</volume>
        <fpage>827</fpage>
        <lpage>832</lpage>
        <pub-id pub-id-type="pmid">23873081</pub-id>
      </element-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cradick</surname>
            <given-names>T.J.</given-names>
          </name>
          <name>
            <surname>Fine</surname>
            <given-names>E.J.</given-names>
          </name>
          <name>
            <surname>Antico</surname>
            <given-names>C.J.</given-names>
          </name>
          <name>
            <surname>Bao</surname>
            <given-names>G.</given-names>
          </name>
        </person-group>
        <article-title>CRISPR/Cas9 systems targeting β-globin and CCR5 genes
                        have substantial off-target activity</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2013</year>
        <volume>41</volume>
        <fpage>9584</fpage>
        <lpage>9592</lpage>
        <pub-id pub-id-type="pmid">23939622</pub-id>
      </element-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Guilinger</surname>
            <given-names>J.P.</given-names>
          </name>
          <name>
            <surname>Pattanayak</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Reyon</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Tsai</surname>
            <given-names>S.Q.</given-names>
          </name>
          <name>
            <surname>Sander</surname>
            <given-names>J.D.</given-names>
          </name>
          <name>
            <surname>Joung</surname>
            <given-names>J.K.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>D.R.</given-names>
          </name>
        </person-group>
        <article-title>Broad specificity profiling of TALENs results in engineered
                        nucleases with improved DNA-cleavage specificity</article-title>
        <source>Nature methods</source>
        <year>2014</year>
        <volume>11</volume>
        <fpage>429</fpage>
        <lpage>35</lpage>
        <pub-id pub-id-type="pmid">24531420</pub-id>
      </element-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xiao</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Kong</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>B.</given-names>
          </name>
        </person-group>
        <article-title>CasOT: a genome-wide Cas9/gRNA off-target searching
                        tool</article-title>
        <article-title>Bioinformatics</article-title>
        <year>2014</year>
        <volume>30</volume>
        <fpage>1180</fpage>
        <lpage>1182</lpage>
      </element-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Heigwer</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Kerr</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Boutros</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>E-CRISP: fast CRISPR target site identification</article-title>
        <source>Nat. Methods</source>
        <year>2014</year>
        <volume>11</volume>
        <fpage>122</fpage>
        <lpage>123</lpage>
        <pub-id pub-id-type="pmid">24481216</pub-id>
      </element-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Heigwer</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Kerr</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Walther</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Glaeser</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Pelz</surname>
            <given-names>O.</given-names>
          </name>
          <name>
            <surname>Breinig</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Boutros</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>E-TALEN: a web tool to design TALENs for genome
                        engineering</article-title>
        <article-title>Nucleic Acids Res.</article-title>
        <year>2013</year>
        <volume>41</volume>
        <fpage>1</fpage>
        <lpage>7</lpage>
      </element-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Neff</surname>
            <given-names>K.L.</given-names>
          </name>
          <name>
            <surname>Argue</surname>
            <given-names>D.P.</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>A.C.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>H.B.</given-names>
          </name>
          <name>
            <surname>Clark</surname>
            <given-names>K.J.</given-names>
          </name>
          <name>
            <surname>Ekker</surname>
            <given-names>S.C.</given-names>
          </name>
        </person-group>
        <article-title>Mojo Hand, a TALEN design tool for genome editing
                        applications</article-title>
        <source>BMC Bioinformatics</source>
        <year>2013</year>
        <volume>14</volume>
        <fpage>1</fpage>
        <pub-id pub-id-type="pmid">23323762</pub-id>
      </element-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Doyle</surname>
            <given-names>E.L.</given-names>
          </name>
          <name>
            <surname>Booher</surname>
            <given-names>N.J.</given-names>
          </name>
          <name>
            <surname>Standage</surname>
            <given-names>D.S.</given-names>
          </name>
          <name>
            <surname>Voytas</surname>
            <given-names>D.F.</given-names>
          </name>
          <name>
            <surname>Brendel</surname>
            <given-names>V.P.</given-names>
          </name>
          <name>
            <surname>Vandyk</surname>
            <given-names>J.K.</given-names>
          </name>
          <name>
            <surname>Bogdanove</surname>
            <given-names>A.J.</given-names>
          </name>
        </person-group>
        <article-title>TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL
                        effector design and target prediction</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2012</year>
        <volume>40</volume>
        <fpage>W117</fpage>
        <lpage>W122</lpage>
        <pub-id pub-id-type="pmid">22693217</pub-id>
      </element-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sander</surname>
            <given-names>J.D.</given-names>
          </name>
          <name>
            <surname>Zaback</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Joung</surname>
            <given-names>J.K.</given-names>
          </name>
          <name>
            <surname>Voytas</surname>
            <given-names>D.F.</given-names>
          </name>
          <name>
            <surname>Dobbs</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>Zinc Finger Targeter (ZiFiT): an engineered zinc finger/target
                        site design tool</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2007</year>
        <volume>35</volume>
        <fpage>W599</fpage>
        <lpage>W605</lpage>
        <pub-id pub-id-type="pmid">17526515</pub-id>
      </element-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gratz</surname>
            <given-names>S.J.</given-names>
          </name>
          <name>
            <surname>Ukken</surname>
            <given-names>F.P.</given-names>
          </name>
          <name>
            <surname>Rubinstein</surname>
            <given-names>C.D.</given-names>
          </name>
          <name>
            <surname>Thiede</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Donohue</surname>
            <given-names>L.K.</given-names>
          </name>
          <name>
            <surname>Cummings</surname>
            <given-names>A.M.</given-names>
          </name>
          <name>
            <surname>O'Connor-Giles</surname>
            <given-names>K.M.</given-names>
          </name>
        </person-group>
        <article-title>Highly specific and efficient CRISPR/Cas9-catalyzed
                        homology-directed repair in Drosophila.</article-title>
        <source>Genetics</source>
        <year>2014</year>
        <volume>196</volume>
        <fpage>961</fpage>
        <lpage>971</lpage>
        <pub-id pub-id-type="pmid">24478335</pub-id>
      </element-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Langmead</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Trapnell</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Pop</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Salzberg</surname>
            <given-names>S.L.</given-names>
          </name>
        </person-group>
        <article-title>Ultrafast and memory-efficient alignment of short DNA sequences
                        to the human genome</article-title>
        <source>Genome Biol.</source>
        <year>2009</year>
        <volume>10</volume>
        <fpage>R25</fpage>
        <pub-id pub-id-type="pmid">19261174</pub-id>
      </element-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Karolchik</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Hinrichs</surname>
            <given-names>A.S.</given-names>
          </name>
          <name>
            <surname>Furey</surname>
            <given-names>T.S.</given-names>
          </name>
          <name>
            <surname>Roskin</surname>
            <given-names>K.M.</given-names>
          </name>
          <name>
            <surname>Sugnet</surname>
            <given-names>C.W.</given-names>
          </name>
          <name>
            <surname>Haussler</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Kent</surname>
            <given-names>W.J.</given-names>
          </name>
        </person-group>
        <article-title>The UCSC Table Browser data retrieval tool</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2004</year>
        <volume>32</volume>
        <fpage>D493</fpage>
        <lpage>D496</lpage>
        <pub-id pub-id-type="pmid">14681465</pub-id>
      </element-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bostock</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Ogievetsky</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Heer</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>D<sup>3</sup>: Data-Driven Documents</article-title>
        <source>IEEE Trans. Vis. Comput. Graph.</source>
        <year>2011</year>
        <volume>17</volume>
        <fpage>2301</fpage>
        <lpage>2309</lpage>
        <pub-id pub-id-type="pmid">22034350</pub-id>
      </element-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Untergasser</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Cutcutache</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Koressaar</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Faircloth</surname>
            <given-names>B.C.</given-names>
          </name>
          <name>
            <surname>Remm</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Rozen</surname>
            <given-names>S.G.</given-names>
          </name>
        </person-group>
        <article-title>Primer3—new capabilities and interfaces</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2012</year>
        <volume>40</volume>
        <fpage>e115</fpage>
        <pub-id pub-id-type="pmid">22730293</pub-id>
      </element-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>H.J.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>H.J.</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Cho</surname>
            <given-names>S.W.</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>J.-S.</given-names>
          </name>
        </person-group>
        <article-title>Targeted genome editing in human cells with zinc finger nucleases
                        constructed via modular assembly</article-title>
        <source>Genome Res.</source>
        <year>2009</year>
        <volume>19</volume>
        <fpage>1279</fpage>
        <lpage>1288</lpage>
        <pub-id pub-id-type="pmid">19470664</pub-id>
      </element-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ran</surname>
            <given-names>F.A.</given-names>
          </name>
          <name>
            <surname>Hsu</surname>
            <given-names>P.D.</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>C.-Y.</given-names>
          </name>
          <name>
            <surname>Gootenberg</surname>
            <given-names>J.S.</given-names>
          </name>
          <name>
            <surname>Konermann</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Trevino</surname>
            <given-names>A.E.</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>D.A.</given-names>
          </name>
          <name>
            <surname>Inoue</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Matoba</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Double nicking by RNA-guided CRISPR Cas9 for enhanced genome
                        editing specificity</article-title>
        <article-title>Cell</article-title>
        <year>2013</year>
        <volume>154</volume>
        <fpage>1380</fpage>
        <lpage>1389</lpage>
      </element-citation>
    </ref>
  </ref-list>
</back>
